1. Home
  2. ZUMZ vs LUNG Comparison

ZUMZ vs LUNG Comparison

Compare ZUMZ & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zumiez Inc.

ZUMZ

Zumiez Inc.

N/A

Current Price

$14.32

Market Cap

304.2M

ML Signal

N/A

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.87

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZUMZ
LUNG
Founded
1978
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
304.2M
97.1M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ZUMZ
LUNG
Price
$14.32
$1.87
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$18.00
$5.38
AVG Volume (30 Days)
165.7K
395.5K
Earning Date
06-04-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
966.67
7.64
EPS
N/A
N/A
Revenue
$929,057,000.00
$90,497,000.00
Revenue This Year
$4.30
$2.48
Revenue Next Year
$3.30
$18.46
P/E Ratio
N/A
N/A
Revenue Growth
4.48
8.01
52 Week Low
$15.00
$1.13
52 Week High
$31.70
$2.89

Technical Indicators

Market Signals
Indicator
ZUMZ
LUNG
Relative Strength Index (RSI) 34.38 38.64
Support Level $15.00 $1.20
Resistance Level $19.05 $2.49
Average True Range (ATR) 0.64 0.15
MACD -0.09 -0.08
Stochastic Oscillator 1.06 7.74

Price Performance

Historical Comparison
ZUMZ
LUNG

About ZUMZ Zumiez Inc.

Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: